Influence of of Smoothened molecular expression on RhoA/ROCK signaling pathway in fibroblast-like synoviocytes from rheumatoid arthritis

Weixiang Peng,Shangling Zhu,Xiaoxue Feng,Zhuofeng Lin,Jianlin Huang

DOI: https://doi.org/10.3877/cma.j.issn.1674-0785.2014.04.020

2014-01-01

Abstract:Objective By investigating the expression of Sonic Hedgehog signaling pathway-associated factor Smoothened (Smo) of fibroblast-like synoviocytes from active rheumatoid arthritis (RA-FLS) and its effect on RhoA/ROCK signaling pathway, to study the regulation of Smo in non-canonical Hh pathway. Methods The synovial tissue which was taken from surgery of RA patients was mechanically separated and used to establish the cell model of primary RA-FLS by using explants-culture. Furthermore, fibroblasts'cell purity was identified by testing positive expression of CD55 with flow cytometry. The RA-FLS was treated with Purmorphamine (Smo agonist), KAAD-Cyclopamine (Smo inhibitor) or DMSO (as blank control). The RhoA activity was measured by a pull-down assay;The ROCK activity (expression of MYPT1 protein) and the expression of Smo protein were assessed by Western blot. Results Compared with the control group, the protein expression of Smo, the activities of RhoA and ROCK (expression of MYPT1 protein) were increased in Purmorphamine group while decreased in KAAD-Cyclopamine groups (P<0.05). Conclusion Smo may contribute to the modulation of the RhoA/ROCK pathway and also be the keypoint which links the Shh signaling pathway and the Rho pathway together in RA-FLS.